BridgeBio Pharma, Inc.
US ˙ NasdaqGS ˙ US10806X1028

SecurityBBIO / BridgeBio Pharma, Inc.
InstitutionPoint72 Asset Management, L.P.
ManagerSteven Cohen
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Point72 Asset Management, L.P. ownership in BBIO / BridgeBio Pharma, Inc.

On August 14, 2025 - Point72 Asset Management, L.P. filed a 13F-HR form disclosing ownership of 0 shares of BridgeBio Pharma, Inc. (US:BBIO) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR/A on July 21, 2025 disclosing 198,780 shares of BridgeBio Pharma, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Point72 Asset Management, L.P. has a history of taking positions in derivatives of the underlying security (BBIO) in the form of stock options. The firm currently holds call options representing 23,600 of underlying shares valued at $1,752,536 USD and put options representing 23,600 of underlying shares valued at $1,752,536 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BBIO / BridgeBio Pharma, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-14 2025-06-30 13F BRIDGEBIO PHARMA COM 10806X102 0 -198,780 -100.00 0 -100.00
2025-07-21 2025-03-31 13F/A-1 BRIDGEBIO PHARMA COM 10806X102 198,780 198,780 6,872 0.0157
2025-05-15 2025-03-31 13F BRIDGEBIO PHARMA COM 10806X102 198,780 198,780 6,872 0.0157
2024-02-14 2023-12-31 13F BRIDGEBIO PHARMA COM 10806X102 0 -5,265 -100.00 0 -100.00
2023-11-14 2023-09-30 13F BRIDGEBIO PHARMA COM 10806X102 5,265 -61,409 -92.10 139 -87.96 0.0004
2023-08-14 2023-06-30 13F BRIDGEBIO PHARMA COM 10806X102 66,674 -32,500 -32.77 1,147 -30.29 0.0034
2023-05-15 2023-03-31 13F BRIDGEBIO PHARMA COM 10806X102 99,174 99,174 1,644 0.0051
2022-05-16 2022-03-31 13F BRIDGEBIO PHARMA COM 10806X102 0 -50,312 -100.00 0 -100.00
2022-02-14 2021-12-31 13F BRIDGEBIO PHARMA COM 10806X102 50,312 50,312 839 0.0034
2019-11-15 2019-09-30 13F BRIDGEBIO PHARMA COM 10806X102 0 -13,200 -100.00 0 -100.00
2019-08-14 2019-06-30 13F BRIDGEBIO PHARMA COM 10806X102 13,200 13,200 356 0.0019
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BRIDGEBIO PHARMA COM Call 23,600 521.05 1,753 504.14 n/a n/a n/a
2026-02-17 2025-12-31 13F BRIDGEBIO PHARMA COM Call 3,800 291 n/a n/a n/a
2025-08-14 2025-06-30 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-07-21 2025-03-31 13F/A BRIDGEBIO PHARMA COM Call 100,000 3,457 n/a n/a n/a
2025-05-15 2025-03-31 13F BRIDGEBIO PHARMA COM Call 100,000 3,457 n/a n/a n/a
2024-11-14 2024-09-30 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-09-16 2024-06-30 13F/A BRIDGEBIO PHARMA COM Call 30,000 760 n/a n/a n/a
2024-08-19 2024-06-30 13F/A BRIDGEBIO PHARMA COM Call 30,000 760 n/a n/a n/a
2024-08-14 2024-06-30 13F BRIDGEBIO PHARMA COM Call 30,000 760 n/a n/a n/a
2022-05-16 2022-03-31 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F BRIDGEBIO PHARMA COM Call 30,700 512 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BRIDGEBIO PHARMA COM Put 23,600 521.05 1,753 504.14 n/a n/a n/a
2026-02-17 2025-12-31 13F BRIDGEBIO PHARMA COM Put 3,800 291 n/a n/a n/a
2025-08-14 2025-06-30 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-07-21 2025-03-31 13F/A BRIDGEBIO PHARMA COM Put 30,000 -50.00 1,037 -37.00 n/a n/a n/a
2025-05-15 2025-03-31 13F BRIDGEBIO PHARMA COM Put 30,000 1,037 n/a n/a n/a
2025-02-14 2024-12-31 13F BRIDGEBIO PHARMA COM Put 60,000 71.43 1,646 84.74 n/a n/a n/a
2024-11-14 2024-09-30 13F BRIDGEBIO PHARMA COM Put 35,000 891 n/a n/a n/a
2024-05-15 2024-03-31 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F BRIDGEBIO PHARMA COM Put 50,000 2,018 n/a n/a n/a
2023-08-14 2023-06-30 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F BRIDGEBIO PHARMA COM Put 35,000 580 n/a n/a n/a
2022-05-16 2022-03-31 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F BRIDGEBIO PHARMA COM Put 52,200 871 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.